Safety tolerance oral dextromethorphan patients risk brain ischemia Experimental ischemia models antitussive dextromethorphan N-methyl-D-aspartate antagonist neuroprotective properties patients history recent stroke transient ischemic attack oral dextromethorphan mg q.i.d weeks placebo-controlled double-blind crossover tolerance study clinical evidence toxicity attributable preliminary study 